Open AccessP112: Phase II Trial of Brentuximab Vedotin plus ibrutinib in Relapsed/Refractory Hodgkin Lymphoma
HemaspherePeer ReviewedMei Matthew +142022Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support